A new trading day began on Friday, with Genprex Inc (NASDAQ: GNPX) stock price down -7.48% from the previous day of trading, before settling in for the closing price of $2.14. GNPX’s price has ranged from $0.28 to $14.80 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Meanwhile, its annual earnings per share averaged 75.40%. With a float of $2.43 million, this company’s outstanding shares have now reached $2.59 million.
Considering the fact that the conglomerate employs 26 people, you should pay attention to its efficiency factor. In terms of profitability, gross margin is 47.71%, operating margin of -113535.75%, and the pretax margin is -112905.8%.
Genprex Inc (GNPX) Breakdown of a Key Holders of the stock
As we move forward, let’s examine how large-scale investors are investing in this stock of the Biotechnology Industry. The insider ownership of Genprex Inc is 6.26%, while institutional ownership is 10.47%.
Genprex Inc (GNPX) Recent Fiscal highlights
In its latest quarterly report, released on 6/30/2024, the company reported earnings of -5.2 per share, which was $0.1 lower than the consensus estimate of $0.26. In terms of return on equity, this company recorded -19.55% in contrast with 50.0% return on Investment (trailing twelve months). Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.68 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 75.40% per share during the next fiscal year.
Genprex Inc (NASDAQ: GNPX) Trading Performance Indicators
Here are Genprex Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 1.95.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -16.05, a number that is poised to hit -2.73 in the next quarter and is forecasted to reach -1.65 in one year’s time.
Technical Analysis of Genprex Inc (GNPX)
Compared to the last year’s volume of 2.7 million, its volume of 101.19 million showed improvement in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 53.36%. Additionally, its Average True Range was 0.42.
During the past 100 days, Genprex Inc’s (GNPX) raw stochastic average was set at 46.06%, which indicates a significant increase from 45.83% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 652.56% in the past 14 days, which was higher than the 276.97% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.6559, while its 200-day Moving Average is $2.7067. Nevertheless, the first resistance level for the watch stands at $2.2602 in the near term. At $2.5403, the stock is likely to face the second major resistance level. The third major resistance level sits at $2.7607. If the price goes on to break the first support level at $1.7597, it is likely to go to the next support level at $1.5393. Now, if the price goes above the second support level, the third support stands at $1.2592.
Genprex Inc (NASDAQ: GNPX) Key Stats
With a market capitalization of 5.13 million, the company has a total of 2,099K Shares Outstanding. Currently, annual sales are 0 K while annual income is -30,860 K. The company’s previous quarter sales were 0 K while its latest quarter income was -6,500 K.
